DN-1406131

N/A

Report date: 2025/01/02 16:12:10
NME

Base Information

Drug NameDN-1406131
Drug Alias NameDN-131DN-1406131
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIndoleamine 2,3-dioxygenase inhibitorsTryptophan 2,3-dioxygenase inhibitors
TargetsTryptophan 2,3-dioxygenaseIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesShanghai De Novo Pharmatech Co LtdJiangxi Qingfeng Pharmaceutical Industry Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai De Novo Pharmatech Co LtdJiangxi Qingfeng Pharmaceutical Industry Co Ltd
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungMelanoma

Other Information

ATC CodeN/A
Related LinksN/A